TIMP2 and cancer: In another model of TIMP-2 and Ala+TIMP-2 in human lung carcinoma cell line A549, TIMP-2 and Ala+TIMP-2-derived A549 cancer cell lines produced significantly suppressed tumor growth compared to empty vector controls as late as 40 days post tumor cell inoculation [248].